| Primary |
| Product Used For Unknown Indication |
12.7% |
| Vulvovaginal Dryness |
12.7% |
| Menopausal Symptoms |
12.2% |
| Atrophic Vulvovaginitis |
10.5% |
| Menopause |
7.1% |
| Hypertension |
5.6% |
| Hormone Replacement Therapy |
5.4% |
| Prophylaxis |
4.9% |
| Drug Use For Unknown Indication |
4.6% |
| Lower Respiratory Tract Infection |
3.9% |
| Anxiety |
3.7% |
| Hypothyroidism |
2.7% |
| Type 2 Diabetes Mellitus |
2.0% |
| Asthma |
1.7% |
| Constipation |
1.7% |
| Flatulence |
1.7% |
| Hypercholesterolaemia |
1.7% |
| Ill-defined Disorder |
1.7% |
| Sinusitis |
1.7% |
| Myocardial Ischaemia |
1.5% |
|
| Breast Cancer |
22.8% |
| Endometrial Cancer |
7.9% |
| Vaginal Haemorrhage |
7.9% |
| Endometrial Cancer Stage Ii |
5.3% |
| Myoclonus |
5.3% |
| Nausea |
4.4% |
| Rash |
4.4% |
| Urticaria |
4.4% |
| Visual Impairment |
4.4% |
| Vulvovaginal Pain |
4.4% |
| Diarrhoea |
3.5% |
| Drug Hypersensitivity |
3.5% |
| Pulmonary Embolism |
3.5% |
| Breast Cancer In Situ |
2.6% |
| Cerebral Haemorrhage |
2.6% |
| Chest Pain |
2.6% |
| Cholelithiasis |
2.6% |
| Drug Ineffective |
2.6% |
| Hypoaesthesia |
2.6% |
| Malaise |
2.6% |
|
| Secondary |
| Hormone Replacement Therapy |
82.5% |
| Menopause |
4.0% |
| Vulvovaginal Dryness |
3.1% |
| Atrophic Vulvovaginitis |
1.8% |
| Product Used For Unknown Indication |
1.2% |
| Menopausal Symptoms |
1.0% |
| Hypertension |
0.8% |
| Type 2 Diabetes Mellitus |
0.7% |
| Diabetes Mellitus |
0.6% |
| Hormone Therapy |
0.6% |
| Hypothyroidism |
0.6% |
| Hot Flush |
0.5% |
| Prophylaxis |
0.5% |
| Migraine |
0.4% |
| Myocardial Ischaemia |
0.4% |
| Night Sweats |
0.4% |
| Blood Cholesterol Abnormal |
0.3% |
| Drug Use For Unknown Indication |
0.3% |
| Premenstrual Syndrome |
0.3% |
| Vulvovaginal Pain |
0.3% |
|
| Breast Cancer Female |
42.2% |
| Breast Cancer |
15.5% |
| Breast Cancer Metastatic |
8.6% |
| Nausea |
3.2% |
| Vaginal Haemorrhage |
3.2% |
| Drug Ineffective |
2.7% |
| Visual Impairment |
2.7% |
| Breast Cancer In Situ |
2.1% |
| Breast Cancer Recurrent |
2.1% |
| Ovarian Epithelial Cancer |
2.1% |
| Uterine Leiomyoma |
2.1% |
| Weight Decreased |
2.1% |
| Deep Vein Thrombosis |
1.6% |
| Metastases To Bone |
1.6% |
| Osteoporosis |
1.6% |
| Road Traffic Accident |
1.6% |
| Vomiting |
1.6% |
| Abdominal Distension |
1.1% |
| Abscess |
1.1% |
| Depression |
1.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.4% |
| Drug Use For Unknown Indication |
17.1% |
| Osteoporosis |
8.0% |
| Hypertension |
5.2% |
| Pain |
4.7% |
| Rheumatoid Arthritis |
4.2% |
| Gastrooesophageal Reflux Disease |
4.1% |
| Asthma |
2.9% |
| Depression |
2.8% |
| Osteopenia |
2.6% |
| Blood Cholesterol Increased |
2.3% |
| Hormone Replacement Therapy |
2.3% |
| Hypothyroidism |
2.3% |
| Supplementation Therapy |
2.0% |
| Anxiety |
1.9% |
| Constipation |
1.9% |
| Diabetes Mellitus |
1.9% |
| Crohn's Disease |
1.8% |
| Vulvovaginal Dryness |
1.8% |
| Gastrointestinal Motility Disorder |
1.7% |
|
| Weight Decreased |
10.3% |
| Vomiting |
8.4% |
| Nausea |
6.5% |
| Weight Increased |
6.5% |
| Urinary Tract Infection |
6.1% |
| Injection Site Pain |
5.6% |
| Drug Ineffective |
4.2% |
| Electrocardiogram Qt Prolonged |
4.2% |
| Headache |
4.2% |
| Hyponatraemia |
4.2% |
| Pain In Extremity |
4.2% |
| Paraesthesia |
4.2% |
| Somnolence |
4.2% |
| Tongue Ulceration |
4.2% |
| Tremor |
4.2% |
| White Blood Cell Count Decreased |
4.2% |
| Diarrhoea |
3.7% |
| Pneumonia |
3.7% |
| Product Quality Issue |
3.7% |
| Pain |
3.3% |
|
